PMGC Holdings Inc. (NASDAQ:ELAB – Free Report)’s stock is scheduled to reverse split before the market opens on Tuesday, March 10th. The 1-6 reverse split was announced on Wednesday, March 4th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, March 9th.
PMGC Stock Performance
NASDAQ:ELAB opened at $0.71 on Friday. PMGC has a fifty-two week low of $0.68 and a fifty-two week high of $114.38. The firm has a market cap of $2.29 million, a PE ratio of -0.01 and a beta of 1.12. The business has a 50 day moving average price of $3.06 and a 200-day moving average price of $14.84.
Analyst Ratings Changes
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of PMGC in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.
PMGC Company Profile
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.
Further Reading
- Five stocks we like better than PMGC
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
